Mast cells initiate lymphocyte egress from distant lymph nodes upon skin inflammation via RANKL-sphingosine-1-phosphate axis
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Receptor activator of NFκB ligand (RANKL) is important for bone metabolism, but also modulates immune processes. We showed that mast cells (MCs) are involved in RANKL regulation, but the importance of MC-derived RANKL in skin inflammation has not yet been investigated. In contact hypersensitivity (CHS), the absence of MC-derived RANKL led to reduced skin inflammation due to impaired leukocyte infiltration and blood lymphopenia. Surprisingly, we observed a massive hyperplasia of the distant inguinal lymph nodes in the absence of MC-RANKL. Using adoptive transfers, flow cytometry and whole-mount 3D imaging, we demonstrated that this was not caused by structural maladaptation, but rather by the inability of lymphocytes to exit in a timely manner. Importantly, RANKL deletion in skin MCs only replicated the effect of LN hyperplasia and blood lymphopenia. Moreover, MCs were involved in serum sphingosine-1-phosphate (S1P) regulation during sensitization and challenge. Intravascular administration of S1P restored timely lymphocyte egress, demonstrating a MC-induced organ-spanning RANKL-S1P axis. Consequently, peripheral skin MC-derived RANKL is essential for the timely lymphocyte egress from distant LNs, which may have important implications for the targeted treatment of inflammatory skin diseases.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Mast cells initiate lymphocyte egress from distant lymph nodes upon skin inflammation via RANKL-sphingosine-1-phosphate axis
- Date Crossref
- 24/09/2026
- Éditeur
- American Society for Clinical Investigation
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Otto-von-Guericke-Universität Magdeburg pays non établi dans la noticeUniversité ou école supérieure
-
Institute for Clinical Immunology and Cell Therapeutics pays non établi dans la noticeStructure de recherche
Otto-von-Guericke-Universität Magdeburg et Institute for Clinical Immunology and Cell Therapeutics.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.